The technology has arrived in the drug lab. But should investors pay up for it?
investment News
Pharmaceuticals,Healthcare/Life Sciences,Manufacturing,Artificial Intelligence/Machine Learning,Cancer,Political/General News,Computer Science,Health,Medical Conditions (Discontinued from 14th July 2026),Sciences/Humanities,Content Types,Columns,SYND,WSJ-PRO-WSJ.com,GCAPI,Eli Lilly,LLY,Novartis,NOVN.EB,CH:NOVN,Eli Lilly’s,Novartis’s,LINK:EN|drn:realtime.linkedarticle.DNCO20260712000037,LINK|i1-WP-WSJ-0003725637,LINK|i2-WP-WSJ-0003725637,artificial intelligence,machine learning,political,general news,sciences,humanities,healthcare,life sciences
-
Lynch co-authored several bestselling investment classics, including One Up on Wall Street, Beating the Street, and Learn to Earn. Known for his accessible and common-sense approach to the stock market, he coined the famous investment mantra, "Invest in what you know." This philosophy empowers everyday individual investors to find market-beating opportunities by observing consumer trends and products in their own daily lives before Wall Street notices them.Beyond his writing and investing career, Lynch is a prominent philanthropist. He works actively through the Lynch Foundation to support education, medical research, and cultural organizations. He continues to serve as a vice chairman of Fidelity Management & Research Company, mentoring new generations of financial analysts.